← Back to Search

Other

PepCan for Cervical Neoplasia

Phase 2
Waitlist Available
Led By Mayumi N Nakagawa, MD, PhD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 15 months from time of last vaccination
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new vaccine called PepCan and a substance called Candin® on women with specific cervical lesions. The goal is to see if these treatments can help the immune system fight off HPV infections and reduce or eliminate the lesions.

Eligible Conditions
  • Cervical Intraepithelial Neoplasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~15 months from time of last vaccination
This trial's timeline: 3 weeks for screening, Varies for treatment, and 15 months from time of last vaccination for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Subjects With Complete Response With the Intention-to-treat (ITT) Analysis
Number of Subjects With Complete Response With the Per-protocol Analysis
Number of Subjects With Complete and Partial Responses With the ITT Analysis
+1 more
Secondary study objectives
Safety Assessed by Injection-related Adverse Events (AEs)

Side effects data

From 2022 Phase 2 trial • 81 Patients • NCT02481414
90%
Injection Site Reaction
29%
Headache
29%
Nausea
24%
Hypokalemia
21%
Hypoalbuminemia
21%
Myalgia
17%
Aspartate Aminotransferase Increased
17%
Anemia
17%
Fatigue
14%
Skin and Subcutaneous Tissue Disorders - Other, Specify
12%
Dizziness
12%
Vaginal Infection
12%
Alanine Aminotransferase Increased
10%
Gastrointestinal Disorders - Other, Specify
10%
Fever
10%
Pain
10%
Flu-like Symptoms
10%
Urinary Tract Infection
10%
Infections and Infestations - Others, Specify
10%
Hypocalcemia
7%
Vaginal Hemorrhage
7%
Hypothyroidism
7%
Creatinine Increased
7%
Back Pain
7%
Unintended Pregnancy
7%
Anxiety
5%
Abdominal Pain
5%
Diarrhea
5%
Bruising
5%
Hemoglobin Increased
5%
White Blood Cell Decreased
5%
Investigations - Other, Specify
5%
Bone Pain
5%
Depression
5%
Dyspareunia
5%
Irregular Menstruation
5%
Reproductive System and Breast Disorders - Other, Specify
5%
Allergic Rhinitis
5%
Dyspnea
5%
Sore Throat
2%
Platelet Count Decreased
2%
Urinary Urgency
2%
Non-Cardiac Chest Pain
2%
Palpitations
2%
Appendicitis
2%
Fetal Death
2%
Sinus Bradycardia
2%
Colitis
2%
Constipation
2%
Bloating
2%
Chest Pain - Cardiac
2%
Localized Edema
2%
Eye Disorders 0 Other, Specify
2%
Vomitting
2%
Stomach Pain
2%
Upper Respiratory Infection
2%
Alkaline Phosphatase Increased
2%
Gastrointestinal Pain
2%
Edema Limbs
2%
Blood Bilirubin Increased
2%
Dehydration
2%
Obesity
2%
Hyperglycemia
2%
Hyponatremia
2%
Muscle Weakness Upper Limb
2%
Osteoporosis
2%
Pain in Extremity
2%
Paresthesia
2%
Somnolence
2%
Hemturia
2%
Breast Pain
2%
Vaginal Pain
2%
Cough
2%
Nasal Congestion
2%
Alopecia
2%
Erythema Multiforme
2%
Rash Acneiform
2%
Skin Ulceration
2%
Hot Flashes
2%
Hypertension
2%
Hypotension
2%
Skin Infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
Candin
PepCan

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PepCanExperimental Treatment1 Intervention
Four injections (one every 3 weeks) of PepCan
Group II: CandinActive Control1 Intervention
Four injections (one every 3 weeks) of Candin
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PepCan
2015
Completed Phase 2
~90

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
494 Previous Clinical Trials
150,466 Total Patients Enrolled
Mayumi N Nakagawa, MD, PhDPrincipal InvestigatorUniversity of Arkansas
~8 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top